Parkev Tatevosian, CFA on $RKLB

Channel profile →Sources cited by the channel: Barclays analyst Dan Levy, Meta management and CEO Mark Zuckerberg, Nike management2 entries

Parkev Tatevosian, CFA has discussed $RKLB in 2 videos since 2026-09-06. The latest, on 2026-10-17, was bearish.

2026-10-17Bearish
“Unfortunate News for Rocket Lab Stock Investors | RKLB Stock Analysis”
AI summary · RKLB delayed Neutron to 2027 and fell 10%, but it is not a buying opportunity: at $53 it trades at 23.5 times forward sales versus his ~$22 fair value, so risk-reward is unappealing and risk too high for the upside. The delay is not existential given $2.3 billion cash, but he awaits a better entry.

Today we received some unfortunate news for Rocket Lab stock investors as the company has postponed the launch of its Neutron rocket once again to 2027.

Remember that this Neutron rocket launch has been postponed several times before, and today's postponement caused the stock price to drop by as much as 14% before it recovered.

It is now trading down by approximately 10% at the time of recording this video.

2026-09-06
“Why Is RocketLab Stock Crashing and is it a Generational Buying Opportunity? | RKLB Stock Analysis”
AI summary · RKLB is overvalued relative to fair value; maintain hold rating and wait for a better entry price.

Rocket Lab remains heavily focused on getting the vehicle to the launch pad in the fourth quarter of 2026. This vehicle is the Neutron, which is still under development and facing a slight delay.

However, the company recorded significant revenue growth in its most recent quarter , achieving growth in both of its sectors. Its overall profit margins are also improving. Investors are wondering whether they should buy Rocket Lab shares despite the Neutron development being delayed to the fourth quarter of 2026.